Cell-Specific Inducible Human APOL1 Risk Variant Expression in Mice Causes Hypertension and Renal Damage
Circulation · 2026
DOI: 10.1161/circulationaha.124.071351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, 2026. Verfasst von Fang Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia (F.L., B.P., M.A.-S., J. Wu, A.R., J. W…. Hauptthemen laut MEDLINE: Apolipoprotein L1, Hypertension, Renal Insufficiency, Chronic, Apolipoproteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIDDK NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Black people bear a disproportionate burden of hypertension and hypertension-attributed chronic kidney disease. A role of apolipoprotein L1 ( APOL1 ) risk variants (RVs; G1 and G2) in these conditions has been proposed, but genetic and observational studies have shown inconsistent results. METHODS: Here, we investigated the causal role of APOL1 RVs using patient samples, transgenic animal models, and in vitro primary cellular experiments. RESULTS: In the human kidney, APOL1 was highly expressed by glomerular podocytes and endothelial cells. Mice with podocyte-specific expression of the APOL1 RV (G2 APOL1 ), but not those with the reference allele (G0), developed severe secondary hypertension after albuminuria and kidney disease. Mice expressing endothelium-specific G2 APOL1 RVs developed mild hypertension with aging, which was exacerbated after unilateral nephrectomy and subsequent high-salt diet feeding. This condition was associated with a slight alteration in kidney function. In vitro and in vivo experiments demonstrated that the APOL1 RV activates the cytosolic nucleotide sensor STING (stimulator of interferon genes), leading to increased production of endothelin 1. Notably, mice with endothelium-specific STING knockout or those treated with an endothelin inhibitor showed protection from G2 APOL1 RV–mediated hypertension. CONCLUSIONS: These findings indicate a role of G2 APOL1 in hypertension development through STING and endothelin 1 activation, offering new precision therapeutics for addressing hypertension in Black people carrying APOL1 RVs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia (F.L., B.P., M.A.-S., J. Wu, A.R., J. Wahba, A.V., C.L., A.A., K.A.K., K.S.).
- Penn-CHOP Kidney Innovation Center, University of Pennsylvania, Philadelphia (F.L., B.P., M.A.-S., J. Wu, A.R., J. Wahba, A.V., C.L., A.A., K.A.K., K.S.).
- Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China (F.L., X.D.).
- Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia (E.C.-M., C.A.H.).
- Department of Medicine, Division of Rheumatology, University of Pennsylvania, Philadelphia (J.J.M.).
ORCID-Profile: Fang Li, Bibek Poudel, Magaiver Andrade-Silva, Junnan Wu, Archana Raman, Elisa Cruz-Morales, Allison Vassalotti, Amin Abedini, Konstantin A Klötzer, Xiaoqiang Ding, Christopher A Hunter, Katalin Susztak
Förderung
- NIH HHS
- NIDDK NIH HHS
- NIAID NIH HHS
- NINDS NIH HHS
Zitieren
APA
Li, F., Poudel, B., Andrade-Silva, M., Wu, J., Raman, A., Cruz-Morales, E., Wahba, J., Vassalotti, A., Li, C., Abedini, A., Klötzer, K. A., Ding, X., Hunter, C. A., Miner, J. J., & Susztak, K. (2026). Cell-Specific Inducible Human APOL1 Risk Variant Expression in Mice Causes Hypertension and Renal Damage. Circulation. https://doi.org/10.1161/circulationaha.124.071351
Vancouver
Li F, Poudel B, Andrade-Silva M, Wu J, Raman A, Cruz-Morales E, et al. Cell-Specific Inducible Human APOL1 Risk Variant Expression in Mice Causes Hypertension and Renal Damage. Circulation. 2026. doi:10.1161/circulationaha.124.071351
BibTeX
@article{Li2026,
author = {Li, Fang and Poudel, Bibek and Andrade-Silva, Magaiver and Wu, Junnan and Raman, Archana and Cruz-Morales, Elisa and Wahba, Joseph and Vassalotti, Allison and Li, Chenyu and Abedini, Amin and Klötzer, Konstantin A and Ding, Xiaoqiang and Hunter, Christopher A and Miner, Jonathan J and Susztak, Katalin},
title = {Cell-Specific Inducible Human APOL1 Risk Variant Expression in Mice Causes Hypertension and Renal Damage},
journal = {Circulation},
year = {2026},
doi = {10.1161/circulationaha.124.071351}
}
EUVIMED